IOWH-032
A novel and potent CFTR inhibitor (IC50=1.01 uM) in T84 and CHO-CFTR cell based assays for the treatment of cystic fibrosis; potentially serves as lead compound for development of new drugs for the treatment of cystic fibrosis. (In Vitro) :IOWH-032 (10 μM; 0-72 h) increases the ACE-2 expression in SARS-CoV-2 infected CFBE41o- WT cells.
Product Specifications
CAS Number
1191252-49-9
Product Name Alternative
IOWH-032 | IOWH032 | IOWH 032
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
O=C (C1=NC (C2=CC (Br) =C (O) C (Br) =C2) =NO1) NCC3=CC=C (OC4=CC=CC=C4) C=C3
Molecular Formula
C22H15Br2N3O4
Molecular Weight
545.1802
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
1,2,4-Oxadiazole-5-carboxamide, 3- (3,5-dibromo-4-hydroxyphenyl) -N-[ (4-phenoxyphenyl) methyl]-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK243930 96 Well
Human PTPLA (Protein Tyrosine Phosphatase Like Protein A) ELISA Kit
Sign In for Pricing
View Details MBS950678 Inquire
Recombinant Chicken NADH-ubiquinone oxidoreductase chain 3 (MT-ND3)
Sign In for Pricing
View Details